Abstract
Traditionally, scientists have focused on structural changes in DNA sequences, such as mutations and deletions, as the cause for altered patterns of gene expression in human cancer. However, a recent explosion of studies indicates that epigenetic changes can be equally important in controlling gene expression. For example, global changes in DNA methylation occur during the progression of breast cancer. These changes include hypomethylation and hypermethylation of chromosomal regions and specific genes that are implicated in the genesis of breast cancer. As an example, we will pay particular attention to two genes, estrogen and progesterone receptor, which have long been associated with breast cancer initiation and progression. Identifying and characterizing these epigenetic modifications may lead to improvements in early detection, prognosis and design of novel therapies for a disease that is one of the leading causes of cancer death among women. This review will describe the changes in DNA meth ylation that have been identified in breast cancer thus far, and their functional consequences, including gene silencing, uncontrolled cell growth, genomic instability and hypermutability. Further, we will discuss the clinical ramifications of these findings.
Keywords: Gene expression, Breast Cancer, DNA methylaion, CpG Island, DNMT, Human cancer, Cell growth, Differentiation, Mammary derived growth inhibitor MDGI, Genetic Stability
Current Genomics
Title: DNA Methylation and Breast Cancer
Volume: 1 Issue: 1
Author(s): A. T. Ferguson and S. J. Nass
Affiliation:
Keywords: Gene expression, Breast Cancer, DNA methylaion, CpG Island, DNMT, Human cancer, Cell growth, Differentiation, Mammary derived growth inhibitor MDGI, Genetic Stability
Abstract: Traditionally, scientists have focused on structural changes in DNA sequences, such as mutations and deletions, as the cause for altered patterns of gene expression in human cancer. However, a recent explosion of studies indicates that epigenetic changes can be equally important in controlling gene expression. For example, global changes in DNA methylation occur during the progression of breast cancer. These changes include hypomethylation and hypermethylation of chromosomal regions and specific genes that are implicated in the genesis of breast cancer. As an example, we will pay particular attention to two genes, estrogen and progesterone receptor, which have long been associated with breast cancer initiation and progression. Identifying and characterizing these epigenetic modifications may lead to improvements in early detection, prognosis and design of novel therapies for a disease that is one of the leading causes of cancer death among women. This review will describe the changes in DNA meth ylation that have been identified in breast cancer thus far, and their functional consequences, including gene silencing, uncontrolled cell growth, genomic instability and hypermutability. Further, we will discuss the clinical ramifications of these findings.
Export Options
About this article
Cite this article as:
Ferguson T. A. and Nass J. S., DNA Methylation and Breast Cancer, Current Genomics 2000; 1 (1) . https://dx.doi.org/10.2174/1389202003351652
DOI https://dx.doi.org/10.2174/1389202003351652 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Developments in Selective Small Molecule ATP-Targeting the Serine/Threonine Kinase Akt/PKB
Mini-Reviews in Medicinal Chemistry Antimalarial Drugs in Pregnancy: A Review
Current Drug Safety Outer Surface Proteins of Borrelia: Peerless Immune Evasion Tools
Current Protein & Peptide Science A Review of Eugenol-based Nanomedicine: Recent Advancements
Current Bioactive Compounds Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects
Current Medicinal Chemistry Pharmaceutical Production of Anti-tumor and Immune-potentiating Enterococcus faecalis-2001 β-glucans: Enhanced Activity of Macrophage and Lymphocytes in Tumor-implanted Mice
Current Pharmaceutical Biotechnology The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
Current Medicinal Chemistry Molecular Modelling, Design, Synthesis and Biochemical Evaluation of a Range of Non-Steroidal Thiosemicarbazone-Based Inhibitors of Estrone Sulfatase (ES) - A Potential Insight into the Action of a Range of Allosteric Inhibitors of ES
Letters in Drug Design & Discovery Malignant Pleural Effusion Evaluation and Management
Current Respiratory Medicine Reviews Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics
Current Signal Transduction Therapy Dietary Quercetin Alleviated DSS-induced Colitis in Mice Through Several Possible Pathways by Transcriptome Analysis
Current Pharmaceutical Biotechnology Prediction of Gene Co-Expression by Quantifying Heterogeneous Features
Current Bioinformatics Overview and Developments Regarding Functional Foods and Beverages
Current Nutrition & Food Science Biotransformation of Endocrine Disrupting Compounds by Selected Phase I and Phase II Enzymes – Formation of Estrogenic and Chemically Reactive Metabolites by Cytochromes P450 and Sulfotransferases
Current Medicinal Chemistry <i>In Vitro</i> Anticancer Activity of Virgin Coconut Oil and its Fractions in Liver and Oral Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Docking Investigation on Bis (Nitro Indazolyl) Methanes; Synthesis and Antimicrobial Activity Towards Breast Cancer Applications
Letters in Organic Chemistry Recent Advances in Medicinal Chemistry of Sulfonamides. Rational Design as Anti-Tumoral, Anti-Bacterial and Anti-Inflammatory Agents
Mini-Reviews in Medicinal Chemistry B Cell Depletion with Rituximab in Graves Disease and Associated Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial (Thematic Issue: "Discovery and Development of New Anticancer Drugs Inspired from Natural Product Leads" Part 1)
Anti-Cancer Agents in Medicinal Chemistry